MODEL VERDICT
XOMA Corporation (XOMAP) — Relative Valuation
Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
XOMA Corporation (XOMAP)
XOMA Corporation (XOMAP) — Relative ValuationPeer multiples, Monte Carlo simulation & quality-adjusted fair value
XOMA Corporation (XOMAP)
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| Feb 28, 2026 | NEUTRAL | 0.16 | $25.89 | CURRENT | — |
| Feb 21, 2026 | NEUTRAL | 0.16 | $25.91 | CURRENT | — |
| Feb 14, 2026 | NEUTRAL | 0.16 | $26.12 | CURRENT | — |
| Feb 11, 2026 | NEUTRAL | 0.30 | $25.85 | CURRENT | — |
| Jan 11, 2026 | MODERATE | 0.60 | $26.63 | Pending | -2.2% |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| Forward P/E 57 analyst estimates | $17.03 | -34.2% | 20% | A- | Analyst Est. |
| EV To Revenue 130 industry peers | $35.65 | +37.7% | 4% | B | Data |
| Price / Sales 130 industry peers | $36.99 | +42.9% | 3% | B | Model Driven |
| Weighted Output Blended model output | $24.78 | -4.3% | 100% | 54 | FAIRLY VALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 3.38 | 3.29 | 2.26 | 5.41 | 1.22 |
| P/B Ratio | 2.97 | 3.29 | 2.26 | 3.70 | 0.66 |
| Div Yield | 0.02 | 0.02 | 0.01 | 0.02 | 0.00 |
| P/S Ratio | 27.41 | 10.63 | 8.40 | 61.26 | 24.91 |
Based on our peer multiples analysis with 8 valuation metrics, the model estimates XOMAP's fair value at $24.78 vs the current price of $25.89, implying -4.3% downside potential. Model verdict: Fairly Valued. Confidence: 54/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $24.78 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $16.41 (P10) to $36.31 (P90), with a median of $25.89.
XOMAP's current P/E of -15.7x compares to the industry median of 21.4x (48 peers in the group). This represents a -173.2% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
9 analysts cover XOMAP with a consensus rating of Buy. The consensus price target is N/A (range: N/A — N/A), implying N/A upside from the current price. Grade breakdown: Strong Buy (0), Buy (5), Hold (4), Sell (0), Strong Sell (0).
The model confidence score is 54/100, based on: data completeness (6), peer quality (25), historical depth (16), earnings stability (5), and model agreement (2). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for XOMAP.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.